Celltrion announced on the 31st that it has signed a joint research and development agreement for a new immuno-oncology drug with MustBio, a domestic ...

The understanding of immune biology and the development of newer generations of immunotherapies have opened a new stage to ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40-billion-pound sales projection ...

Achieved commercially viable yield for IM1240, positioning the program competitively for future developmentValidates ...

Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...

The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, ...

Nanomedicine Innovations Transforming Oncology Drug Delivery And Bioavailability - Financial News Media. NetworkNewsWire Editorial Coverage New York, NY – October 29, 2025 – The global cancer-therapy ...

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, ...

From this core mechanism Fc engineering has evolved over time into the "engine" of therapeutic antibody development. It ...

Professor Guan Xinyuan (left) and his research team developed the 'Cancer Immunology Data Engine', which is publicly ...

A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...